LGT Capital Partners LTD. Has $57.30 Million Holdings in Teleflex Incorporated (NYSE:TFX)

LGT Capital Partners LTD. increased its stake in Teleflex Incorporated (NYSE:TFX) by 4.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 231,685 shares of the medical technology company’s stock after acquiring an additional 9,411 shares during the quarter. Teleflex accounts for approximately 2.0% of LGT Capital Partners LTD.’s portfolio, making the stock its 18th largest position. LGT Capital Partners LTD. owned approximately 0.50% of Teleflex worth $57,300,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Oregon Public Employees Retirement Fund boosted its position in shares of Teleflex by 1.2% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock worth $846,000 after purchasing an additional 46 shares in the last quarter. Cromwell Holdings LLC boosted its holdings in Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after acquiring an additional 49 shares in the last quarter. Crossmark Global Holdings Inc. boosted its holdings in Teleflex by 1.9% in the second quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock worth $584,000 after acquiring an additional 53 shares in the last quarter. Apollon Wealth Management LLC grew its stake in Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock valued at $377,000 after acquiring an additional 55 shares during the period. Finally, SRS Capital Advisors Inc. increased its holdings in shares of Teleflex by 0.3% during the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after acquiring an additional 60 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analyst Ratings Changes

TFX has been the subject of several research reports. Stephens lifted their price target on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th. Royal Bank of Canada cut their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho lowered their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Finally, Truist Financial reiterated a “hold” rating and set a $227.00 price target (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Teleflex has an average rating of “Moderate Buy” and an average target price of $259.25.

Teleflex Stock Performance

Shares of TFX opened at $194.43 on Tuesday. Teleflex Incorporated has a 52-week low of $189.95 and a 52-week high of $257.85. The stock has a market capitalization of $9.03 billion, a price-to-earnings ratio of 38.65, a price-to-earnings-growth ratio of 1.97 and a beta of 1.18. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock’s 50-day simple moving average is $230.35 and its 200 day simple moving average is $223.37.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. During the same quarter in the prior year, the firm posted $3.64 EPS. Teleflex’s revenue was up 2.4% on a year-over-year basis. Research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.70%. The ex-dividend date is Friday, November 15th. Teleflex’s dividend payout ratio is 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.